We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
(+4.7%)
Cap. Flow
+$1.58M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$7.05M |
| 2 |
Amazon
AMZN
|
+$3.89M |
| 3 |
uniQure
QURE
|
+$2.86M |
| 4 |
BioNTech
BNTX
|
+$2.81M |
| 5 |
DexCom
DXCM
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.6M |
| 2 |
Procter & Gamble
PG
|
+$3.27M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.16M |
| 4 |
CVS Health
CVS
|
+$3.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.23% |
| 2 | Healthcare | 25.2% |
| 3 | Consumer Discretionary | 20.47% |
| 4 | Communication Services | 8.05% |
| 5 | Financials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
BioAtla
BCAB
$5.61M
| $3.87K | ﹤0.01% |
9
+2
| +29% | +$830 |
|
|
EGRX
327
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.86K | ﹤0.01% |
132
+8
| +6% | +$254 |
|
328
Fulcrum Therapeutics
FULC
$284M
| $3.85K | ﹤0.01% |
529
+42
| +9% | +$274 |
|
329
Kodiak Sciences
KOD
$2.72B
| $3.81K | ﹤0.01% |
532
+45
| +9% | +$323 |
|
|
NSTG
330
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.78K | ﹤0.01% |
474
+39
| +9% | +$338 |
|
331
Monte Rosa Therapeutics
GLUE
$1.36B
| $3.74K | ﹤0.01% |
492
+55
| +13% | +$458 |
|
332
Arbutus Biopharma
ABUS
$907M
| $3.71K | ﹤0.01% |
1,590
+186
| +13% | +$445 |
|
333
Stoke Therapeutics
STOK
$2.13B
| $3.7K | ﹤0.01% |
401
+32
| +9% | +$333 |
|
334
Lexicon Pharmaceuticals
LXRX
$1.05B
| $3.66K | ﹤0.01% |
1,918
+199
| +12% | +$423 |
|
|
TSVT
335
DELISTED
2seventy bio
TSVT
| $3.62K | ﹤0.01% |
+386
| New | +$5.45K |
|
|
ALPN
336
DELISTED
Alpine Immune Sciences Inc
ALPN
| $3.43K | ﹤0.01% |
467
+182
| +64% | +$1.16K |
|
337
Precigen
PGEN
$2.45B
| $3.21K | ﹤0.01% |
2,114
+164
| +8% | +$282 |
|
338
PepsiCo
PEP
$189B
| $3.21K | ﹤0.01% |
+4
| New | +$713 |
|
339
PepGen
PEPG
$201M
| $3.21K | ﹤0.01% |
+240
| New | +$3.1K |
|
340
Atara Biotherapeutics
ATRA
$83.1M
| $3.16K | ﹤0.01% |
39
+4
| +11% | +$417 |
|
|
HLTH
341
DELISTED
Cue Health Inc. Common Stock
HLTH
| $3.14K | ﹤0.01% |
+1,518
| New | +$4.8K |
|
342
Codexis
CDXS
$172M
| $3.11K | ﹤0.01% |
668
+55
| +9% | +$301 |
|
343
Century Therapeutics
IPSC
$353M
| $3.07K | ﹤0.01% |
599
+48
| +9% | +$453 |
|
344
Nkarta
NKTX
$171M
| $2.97K | ﹤0.01% |
496
+40
| +9% | +$404 |
|
345
MeiraGTx Holdings
MGTX
$1.2B
| $2.97K | ﹤0.01% |
455
+37
| +9% | +$254 |
|
346
C4 Therapeutics
CCCC
$480M
| $2.93K | ﹤0.01% |
497
+39
| +9% | +$323 |
|
|
GRTS
347
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.92K | ﹤0.01% |
847
+164
| +24% | +$468 |
|
|
CNCE
348
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.84K | ﹤0.01% |
+487
| New | +$2.56K |
|
349
Karyopharm Therapeutics
KPTI
$46M
| $2.81K | ﹤0.01% |
55
+5
| +10% | +$347 |
|
|
GTHX
350
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.79K | ﹤0.01% |
514
+113
| +28% | +$947 |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2022 Portfolio in Review
As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
- China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
- China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
- China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
- China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
- China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
- China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.
Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.